IP Library Granted Patent US 8,513,380
Granted Patent B2
US 8,513,380 · App. 13/382,466 · Granted Aug 20, 2013

Peptides for binding fibrinogen and fibrin

Inventor: Thomas Harrison Barker (Atlanta, GA)
Assignee: Georgia Tech Research Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,513,380
App. No.
13/382,466
Granted
Aug 20, 2013
Kind
B2
Abstract

Compositions and methods for targeting substances to fibrinogen, fibrin monomers, or fibrin polymers are provided. These compositions and methods generally involve the use of fibrin knob peptides that bind fibrin(ogen), which can be used to detect fibrin(ogen) and modulate fibrin polymerization and fibrinolysis.

Claims (7)

1. A recombinant fusion protein, comprising a fibrin knob peptide selected from the group consisting of SEQ ID NOs:5-8 at the N-terminus of the fusion protein, wherein the fusion protein binds fibrin.

2. The recombinant fusion protein of claim 1 , further comprising a bioactive polypeptide that promotes wound healing or fibrinolysis.

3. The recombinant fusion protein of claim 2 , wherein the bioactive polypeptide is a growth factor, cytokine, adhesion domain, anti-adhesion domain, immunomodulatory domain, protein-binding domain, nucleic acid-binding domain, polysaccharide-binding domain, virus-binding domain, cytotoxic domain, enzymatically active domain, protease inhibitor, serum protein, or fragment thereof, that binds its receptor.

4. The recombinant fusion protein of claim 3 , wherein the bioactive polypeptide is tissue plasminogen activator (tPA), or a fragment thereof that promotes fibrinolysis.

5. The recombinant fusion protein of claim 1 , further comprising an inert protein that sterically hinders fibrin polymerization when the fusion protein binds fibrin.

6. The recombinant fusion protein of claim 5 , wherein the inert protein is human serum albumin.

7. The recombinant fusion protein of claim 1 , conjugated to a polyethylene glycol.

Assignments (2)
CONFIRMATORY LICENSE Recorded Oct 28, 2013
From: GEORGIA TECH RESEARCH CORPORATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031499/0733 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2012
From: BARKER, THOMAS HARRISON
To: GEORGIA TECH RESEARCH CORPORATION
Reel/Frame 027509/0965 →
Continuity (2)
Provisional Application 61224188 · Jul 9, 2009
Related Publication 20120114682A1 · May 10, 2012